Skip to main content
Premium Trial:

Request an Annual Quote

Gentel Licenses OHSU Viral Antigens for its Simian Assay

NEW YORK (GenomeWeb News) – Gentel Biosciences today announced a licensing deal with Oregon Health & Science University covering viral antigens for use on its Colony Surveillance Assays.

The deal is for worldwide commercial use, and the addition of the antigens complements Gentel's strategy to grow its product line to support translational research disease models, it said.

The antigens were developed at the molecular virology laboratory at OHSU's Oregon National Primate Research Center. They will be added to Gentel's CSA: Simian Basic panel, which includes six infectious agents monitored in specific pathogen-free primates. The CSA: Simian Expanded panel will include 11 tests — the six from the Basic panel plus five additional infectious agents.

The expanded panel will be launched in the fall and will run on the Madison, Wis.-based firm's Gentel Proteomics Multi-System platform.

"Our main goal is to allow colony managers to get the lowest false positive/negative rates, in hours and at a significantly lower cost," Alex Vodenlich, president and CEO of Gentel, said in a statement. "Our second goal is to offer a broad enough selection of products that we can serve every [non-human primate] colony in the world. Working with OHSU helps us reach these goals."

Financial and other terms of the deal were not disclosed.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.